ClinicalTrials.gov record NCT07702123

Efficacy of Physical Activity Program in Metabolic-syndrome Females With Behcet Disease

Record copied from ClinicalTrials.gov: Oct 10, 2026AI summaries generated: Sep 16, 2026

Efficacy of Physical Activity Program in Metabolic-syndrome Females With Behcet Disease

StatusRecruitingThe study is currently enrolling participants. Only the study team can say whether a particular person can join.
Study typeInterventionalA study in which researchers assign participants to one or more interventions, such as a drug, procedure, device, behavioural programme or other approach, to measure their effects.
Age40 years old to 50 years old
SexFemale
LocationEgypt
AI summaryWhat this study is about, in plain languageShow ▾Hide ▴

AI-written from the registry record, not the study's own wording. May contain errors or omissions. Check the registry text on this page and the original record ↗ before acting on it.

This randomized study assigns women with Metabolic Syndrome and Behcet Disease to a 12-week treadmill walking program or a waitlist. The exercise group walks on a treadmill 40 minutes, three times per week; the waitlist group does not receive the exercise during the study. Researchers measure HDL (primary outcome), other metabolic and body measurements, blood pressure, fitness, and several questionnaires after 12 weeks.

What it is studying. The study is testing whether a treadmill walking program (40 minutes, three times weekly for 12 weeks) affects HDL cholesterol and other metabolic markers, physical fitness, body measurements, blood pressure, and patient-reported outcomes compared with a waitlist group.

What the researchers hope to learn. To evaluate effects of a 12-week treadmill walking program on high-density lipoprotein (HDL) cholesterol (primary outcome), other lipids and fasting glucose, body mass index and waist circumference, systolic and diastolic blood pressure, cardiopulmonary fitness (Ruffier index), and patient-reported measures including vitality, sleep quality, fatigue, anxiety, depression, satisfaction with life, and Behcet-related quality of life.

What this study is about

The study's own summary, as published on ClinicalTrials.gov. Underlined terms have a short explanation.

metabolci syndrom is highly prevalent in behcet disorder females. usually physical activity is recommended to solve this problem

Interventions being studied

Being studied in this trial does not mean the treatment or procedure is approved or available for this condition.

Behavioral
  • treadmill walking

Eligibility

The criteria exactly as listed on ClinicalTrials.gov. Only the study team can say whether they apply to you.

Inclusion criteria

  • females with metabolci syndrome
  • females with behcet disorder

Exclusion criteria

  • psychatric diseases women
  • mental diseased women

Study description and what participation involves

The study's detailed description, as published on ClinicalTrials.gov.

Detailed description from the registry

metabolci syndrom-fenales with behcet disorder (n=40) were assigned to group I or group II. Group I will perform treadmill walk for 40 minutes. group II will act as waitlist. the group will contian 20 females

AI summaryWhat participation may involve, in plain languageShow ▾Hide ▴

AI-written from the registry record, not the study's own wording. May contain errors or omissions. Check the registry text on this page and the original record ↗ before acting on it.

You will be randomly assigned to one of two groups: a treadmill-walking group or a waitlist group. Participants in the treadmill group will perform treadmill walking for 40 minutes, three times per week, for 12 weeks. Participants in the waitlist group will not take part in the exercise program during the study period. After 12 weeks you will have measurements taken, which include blood tests for lipids and fasting glucose, body measurements (BMI and waist circumference), blood pressure, a simple fitness test (Ruffier index), and several questionnaires about sleep, fatigue, mood, vitality, life satisfaction, and Behcet disease–related quality of life.

How the study is structured. Randomized, parallel assignment with single masking (as listed in the registry). Participants are randomly assigned to either the treadmill-walking group (40 minutes per session, three times weekly, for 12 weeks) or a waitlist control group.

Questions you could ask

These questions are suggestions for a conversation with the study team or your own clinician, not advice.

  • The registry lists this study under Metabolic Syndrome; Behcet Disease. Does it apply to my diagnosis?
  • The listed sites are in Egypt. Is any of them reachable for me, and does the study help with travel?
  • Which of the eligibility criteria would need to be checked with tests before I could join?

More on Behçet's disease

This trial is also listed on this site under familial Mediterranean fever.

Clinical trials34 trials listed for Behçet's diseaseEvery trial the registry lists for Behçet's disease, with recruitment status, phase and sites, updated from ClinicalTrials.gov.See all trials →Research updatesWhat changed in Behçet's disease researchLatest monthly update: September 2026. Includes: Low-dose IL-2 trial. New research summarized each month in plain language, with links to every source paper.Read the latest update →

Important dates

Study start
Jun 2, 2026
Primary completion
Sep 14, 2026 (estimated)
Study completion
Sep 14, 2026 (estimated)
Target enrollment
40 participants (estimated)
Last updated on registry
Jul 14, 2026
Data verified
Oct 10, 2026

Sponsor and research team

The lead sponsor funds and oversees the trial. A pharmaceutical or biotech company sponsor typically means the study is testing that company's drug or device; a hospital, university, or government agency usually indicates investigator-initiated or publicly funded research.

Lead sponsor
Cairo University
Principal investigator
Ali Mohamed Ali ismail, lecturer department of cardiovascular/repsiratory disorder and geriatrics, faculty of physical therpay cairo university
Cairo University

Central study contact

If you're interested in participating, the central contact can answer general questions about the study — including eligibility requirements and how to find a recruiting site near you. Actual eligibility is determined by the site's medical team.

Participating sites (1)

Terms used on this page · explanations by MedicalUpdates.ai

Inclusion Criteria
The conditions a person must meet to be considered for the study, for example a confirmed diagnosis, an age range or a test result.
Exclusion Criteria
The conditions that rule a person out even if they meet the inclusion criteria, for example other illnesses, certain medicines or pregnancy.

The study record on this page is reproduced from ClinicalTrials.gov, a database of the U.S. National Library of Medicine, where it was submitted by the study sponsor. MedicalUpdates.ai does not own this content, is not affiliated with or endorsed by ClinicalTrials.gov, NIH, or the U.S. Government, and does not verify the record. Plain-language notes, the glossary and the questions above are added by this site; text in the boxes marked "AI summary" was written by an AI model and may contain errors. Registry records change over time. Check the original record for the current version and discuss eligibility or participation with a qualified healthcare professional.

← Back to clinical trials